SacroMesh: renewal of listing on the intra-GHS list

Designed and manufactured by Cousin, Sacromesh is a prosthetic reinforcement implant specifically designed for abdominal sacrocolpopexy in the treatment of genital prolapse.

By Order of October 1, 2026, the listing of the SacroMesh device on the list of health products funded under hospitalization benefits (the “intra-GHS” list), referred to in Article L. 165-11 of the French Social Security Code, has been renewed.

This listing is valid until September 29, 2029.

Legal notice

Sacromesh is a Class III medical device manufactured by COUSIN BIOTECH S.A.S. CE conformity was assessed by the notified body DQS MED (CE0297). COUSIN BIOTECH S.A.S.’s management system is certified compliant with ISO 13485 (2016).

Recommendations for use: Carefully read the labeling, instructions for use, and surgical technique before any procedure.